Delhi: Presence of dangerous substances found in Indian-made cough medicine. These are the substances found in the cough medicine that killed 141 children in Gambia, Uzbekistan and Cameroon. This is the first time in two years that the Central Drugs Standard Control Organization has reported the presence of these substances.
Cough and allergy medicines were found to be dangerous. A Central Drugs Standard Control Organization (CDSCO) report in August found that some samples of medicines manufactured by two pharma companies, Fortes India and Norris Medicines, were adulterated with diethylene and ethylene glycol.
The presence of dangerous substances was found in cough medicines manufactured by Norris Medicines. Diethylene glycol and ethylene glycol have been detected. The presence of dangerous substances was found in Norris Medicines Trimax Expectorant and Silpro Plus Syrup.
Gujarat Food and Drugs Control Administration Commissioner HG Koshia has explained that after visiting the Norris factory last month, he was directed to stop the manufacturing of the drugs and recall the drugs. Koshia also said that the factory does not have adequate water and air handling units. Koshia also said that the company had failed to comply with the norms.
Earlier, the World Health Organization had suggested not to use two drugs, 'DOK-1-Max' (DOK-1-Max) and AMBRONOL (AMBRONOL), manufactured by Noida-based Marion Biotech.
The World Health Organization had also stated that the presence of these toxic substances was detected in an Indian-made cough medicine sold in Iraq and Uzbekistan. The World Health Organization made such a recommendation after testing the samples and finding that they were of poor quality. About 141 children had raised suspicions about their deaths that day.
The Ministry of Health found that the presence of a chemical called ethylene glycol was present in the cough syrups. The same chemical is currently found in Norris Medicines cough syrups. The government has revoked the licenses of 18 pharma companies for allegedly manufacturing fake drugs and testing cough syrups in government labs before exporting them. Experts say steps need to be taken to ensure even greater standards across treatments to prevent long-term damage to India's image as the world's pharmacy.
.jpg)
